Dermatology Month in Review: April 2024
In this review of dermatology news in April, we highlighted several major stories on such topics as cutaneous reactions to COVID-19, topical versus oral minoxidil, and FDA news.
Source: hcplive.com
📰 After Previous News
After Previous News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from After Previous. Real-time updates on events, politics, business and more.
Lazertinib Versus Gefitinib as First-line Treatment in EGFR-mutated Advanced NSCLC
1. Progression-free survival was longer in the lazertinib group vs the gefitinib group (20.6 months vs 9.7 months, with HR 0.45), however, OS data were immature. 2. Treatment-related adverse events were similar across both groups, however, lazertinib had higher rates of parasthesia and pruritus but lower levels of ALT elevations and diarrhea. Evidence Rating Level:
Source: 2minutemedicine.com
New Long-Term Data from the CHRYSALIS Study Show Median
Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung cancer who have a MET positive...
Source: globenewswire.com
Saat Raja Malaka Meminang Putri Majapahit, Dibayang-bayangi Gajah Mada : Okezone Nasional
Hubungan itu kian erat saat Raja Malaka menikahi putri Raja Majapahit - Nasional - Okezone Nasional
Oath Elephant Office Seconds King Propose The Daughter Elephant System Politics Good Luck Oath Elephant Office Brief Entourage Government
Source: okezone.com